Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial(ELEVATE-AF)

NCT06883864 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT06883864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06883864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial(ELEVATE-AF)
Lead sponsor
Beijing Anzhen Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 8, 2025
Completion date
May 1, 2028
Enrollment
146 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), atrial functional mitral regurgitation, catheter ablation